)
Melioidosis, an infectious disease caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei, is increasingly recognized as a major yet neglected public health concern in India. Despite predictive modelling studies estimating that India accounts for a substantial share of global cases, with tens of thousands of infections occurring annually, the disease remains underdiagnosed and under-reported across much of the country. Often referred to as the "great mimicker," melioidosis produces clinical symptoms that closely resemble endemic conditions such as tuberculosis (TB), bacterial pneumonia, and acute sepsis, leading to frequent misdiagnoses and delayed administration of appropriate antimicrobial therapy.
According to the Cleveland Clinic, the infection is primarily acquired through direct contact with contaminated soil or water via skin abrasions, inhalation of aerosolized bacteria during heavy rainfall, or ingestion. Exposure risks surge significantly during the monsoon season, particularly among rural populations, agricultural workers, and individuals with underlying health conditions like diabetes mellitus. Understanding the clinical complexities, diagnostic gaps, and regional impact of melioidosis is critical to reducing case fatality rates and strengthening early surveillance systems in India.
Clinical Spectrum and The Diagnostic Challenge
Burkholderia pseudomallei can affect virtually any organ system, presenting as localized abscesses, severe pneumonia, visceral organ involvement (such as liver and spleen abscesses), or fulminant bacteremic septic shock.
Researchers analyzing clinical cohorts at Indian tertiary care institutions highlight the primary drivers behind delayed detection. "Melioidosis continues to be neglected in the Indian Subcontinent despite bearing about 44% of the global burden," says a study published in the Journal of Pure and Applied Microbiology (Case Series of Melioidosis). "Diagnosis poses a significant challenge since the disease presents a wide range of symptoms and closely mimics tuberculosis and pneumonia both of which are endemic in India. Unawareness of the disease, low index of suspicion among medical professionals, incorrect treatment, and discontinuation contribute to the disease burden."
Standard frontline empiric treatments for routine bacterial infections or tuberculosis are ineffective against B. pseudomallei, which displays natural resistance to a broad spectrum of common antibiotics, including penicillins, macrolides, and early-generation cephalosporins. Successful management requires intravenous administration of specific agents such as ceftazidime or meropenem during the initial intensive phase, followed by prolonged oral eradication therapy using co-trimoxazole to prevent disease relapse.
READ | Bacteria Turn A Virus' Own Weapon Against It: Study
Key Risk Factors and Mortality Drivers in India
Data from Indian clinical investigations demonstrate a strong association between melioidosis, seasonal rainfall, and pre-existing comorbidities:
- Diabetes Mellitus as a Primary Vulnerability: Studies published in Indian medical journals report that diabetes is present in 68% to 80% of confirmed melioidosis cases, making it the single most prominent risk factor for severe disease progression.
- High Case Fatality Rates: In hospital-based observational cohorts, overall mortality rates range from 19.9% to nearly 30%. However, among patients presenting with septic shock, mortality rises sharply to 76%.
- Demographic Distribution: Middle-aged males, particularly agricultural labourers, construction workers, and plumbers with regular exposure to soil and surface water, account for the majority of reported cases.
- Diagnostic Limitations: Standard blood and tissue cultures suffer from low sensitivity in initial stages, leaving up to 40% of potential cases undetected in healthcare facilities lacking automated microbiology platforms like VITEK or MALDI-TOF.
Institutional Surveillance and Policy Imperatives
Because melioidosis is not currently classified as a mandatory reportable disease under national disease surveillance frameworks like the Integrated Disease Surveillance Programme (IDSP), its true epidemiological burden in India remains difficult to quantify fully. Medical experts emphasize that increasing clinical awareness, expanding microbiology laboratory infrastructure at district levels, and establishing targeted screening protocols for diabetic patients presenting with unexplained fever or organ abscesses during monsoon months are vital steps toward mitigating the impact of this lethal pathogen.
Melioidosis represents a severe, hidden health challenge across India. Addressable through early microbiological identification and targeted intravenous antibiotic regimes, overcoming its high mortality rate depends on elevating clinical suspicion among primary care physicians and integrating diagnostic capacity into routine public health reporting.
Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.